s/
Stockslash
⌘K
Stocks
CRBU
Not investment advice · 13F data lagged ~45 days · Full disclaimer
CR

Caribou Biosciences

CRBU13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying CRBU

Top funds mostly added to Caribou Biosciences in Q4 (Oct⁠–⁠Dec)

Buying:
Funds1InsidersCongress
1 fund$1.1M held0.0% avg. weightQ4: 1 bought / 0 sold
13F reports are a snapshot as of Dec 31, 2022; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 10 filings
Net buying$107K
DateInsiderTypeSharesPriceValue
Feb 25, 2026
Timothy P Kelly
CTO
Sold6,228$1.93$12K
Feb 24, 2026
Timothy P Kelly
CTO
Sold3,147$1.96$6K
Feb 24, 2026
Barbara G Mcclung
Sold6,938$1.96$14K
Feb 24, 2026
Ruhi Ahmad Khan
Sold6,938$1.96$14K
Feb 24, 2026
Tina M. Albertson
Sold1,066$1.96$2K
Mar 14, 2025
Rachel E. Haurwitz
President & CEO
Bought20,000$1.02$20K
Feb 21, 2025
Barbara G Mcclung
Sold3,564$1.35$5K
Feb 21, 2025
Ruhi Ahmad Khan
Sold3,564$1.35$5K
Feb 21, 2025
Steven Kanner
Sold3,564$1.35$5K
Jan 29, 2025
Sriram Ryali
CFO
Bought17,360$1.42$25K